Re:Cognition Health (RCH) opened as a private independent service provider in 2011, specializing in cognitive health.
The company later expanded the scope of its services to include medical-legal and clinical research.
Founded by: Dr. Emer MacSweeney, CEO (UK Citizen & resident) and Tom Dent, Chairman (USA Citizen & resident)
The portfolio currently includes 5 centers in the United Kingdom and 1 center in the USA. The first clinical trial center in the USA opened in May 2018. The USA portfolio has additional centers planned in 2020.
Today Re:Cognition Health is recognized as the leading independent provider of clinic services for cognitive disorders with successful award-winning business in:
- Adult acquired and progressive neuro-degenerative diseases
- Traumatic Brain injury –including medicolegal witness reporting and rehabilitation
- International Clinical Trials for Alzheimer’s Disease (AD) and other Central Nervous System (CNS) disorders